A sequel for beginners, part 2: ligand-based drug design — the basics

webinar

Tue, 18 Feb 2014, 17:00 CET (Berlin)

A sequel for beginners, part 2: ligand-based drug design — the basics

“But we don’t have a protein structure!&quot – it’s a common complaint in drug hunting. In fact, you don’t have your back to the wall if you need to spot active compounds in this situation! In this BioSolveIT webinar, you will learn the background to basic techniques such as ligand superposition. By the end of the hour, you will have learned how the impossible becomes possible, intelligently mining for interesting and synthetically feasible leads from gigantically large spaces of potential compounds in just a few minutes.

Current news

CHEMriya Update November
November 11, 2026 11:19 CET
More Chemistry. More Possibilities. The latest update of CHEMriya brings over 794 billion virtual product molecules to your compound exploration. Developed by OTAVA in collaboration with BioSolveIT, this on-demand Chemical Space opens up new opportunities for hit expansion, hit-to-lead optimization, and compound evolution. The November 2026 release combines OTAVA’s chemistry...
Read on
category
Challenge
Winter 2026 Scientific Challenge Deadline Approaching
November 3, 2026 13:18 CET
The Winter 2026 Scientific Challenge is here! We invite researchers from academia (students, postdocs, and professors), non-profit organizations, and independent researchers to take part. Whether you are exploring a new drug discovery idea or looking to advance an existing project, our software can help you take your research further. How...
Read on
CORE by Onepot.AI – Access now with our tools
October 27, 2026 14:38 CET
Bringing Robotic Synthesis to Chemical Space Exploration A new Chemical Space is now available for your compound exploration: onepot’s CORE Space brings over 10 billion virtual product molecules to your drug discovery projects. CORE (Compounds On-demand via Robotic Execution) combines reactions widely used in medicinal chemistry with building blocks that...
Read on